BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21458888)

  • 21. A novel fluorescent method for direct visualization of neurofibrillary pathology in Alzheimer's disease.
    Sun A; Nguyen XV; Bing G
    J Neurosci Methods; 2001 Oct; 111(1):17-27. PubMed ID: 11574116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.
    Luterman JD; Haroutunian V; Yemul S; Ho L; Purohit D; Aisen PS; Mohs R; Pasinetti GM
    Arch Neurol; 2000 Aug; 57(8):1153-60. PubMed ID: 10927795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging.
    Mackenzie IR; Munoz DG
    Neurology; 1998 Apr; 50(4):986-90. PubMed ID: 9566383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.
    Tanprasertsuk J; Johnson EJ; Johnson MA; Poon LW; Nelson PT; Davey A; Martin P; Barbey AK; Barger K; Wang XD; Scott TM
    J Alzheimers Dis; 2019; 70(1):35-49. PubMed ID: 31177211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease.
    Nelson PT; Abner EL; Schmitt FA; Kryscio RJ; Jicha GA; Santacruz K; Smith CD; Patel E; Markesbery WR
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):774-84. PubMed ID: 19535994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of caspase-6 in aging and mild cognitive impairment.
    Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC
    Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.
    Cummings BJ; Pike CJ; Shankle R; Cotman CW
    Neurobiol Aging; 1996; 17(6):921-33. PubMed ID: 9363804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual association pathology in preclinical Alzheimer disease.
    McKee AC; Au R; Cabral HJ; Kowall NW; Seshadri S; Kubilus CA; Drake J; Wolf PA
    J Neuropathol Exp Neurol; 2006 Jun; 65(6):621-30. PubMed ID: 16783172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment.
    Nelson PT; Abner EL; Scheff SW; Schmitt FA; Kryscio RJ; Jicha GA; Smith CD; Patel E; Markesbery WR
    Neurosci Lett; 2009 Feb; 450(3):336-9. PubMed ID: 19010392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Memory performance is related to amyloid and tau pathology in the hippocampus.
    Reitz C; Honig L; Vonsattel JP; Tang MX; Mayeux R
    J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):715-21. PubMed ID: 19258354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases.
    Muramori F; Kobayashi K; Nakamura I
    Psychiatry Clin Neurosci; 1998 Dec; 52(6):593-9. PubMed ID: 9895207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease.
    Haroutunian V; Perl DP; Purohit DP; Marin D; Khan K; Lantz M; Davis KL; Mohs RC
    Arch Neurol; 1998 Sep; 55(9):1185-91. PubMed ID: 9740112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.
    Dugger BN; Davis K; Malek-Ahmadi M; Hentz JG; Sandhu S; Beach TG; Adler CH; Caselli RJ; Johnson TA; Serrano GE; Shill HA; Belden C; Driver-Dunckley E; Caviness JN; Sue LI; Jacobson S; Powell J; Sabbagh MN
    BMC Neurol; 2015 Aug; 15():146. PubMed ID: 26289075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis.
    Farber NB; Rubin EH; Newcomer JW; Kinscherf DA; Miller JP; Morris JC; Olney JW; McKeel DW
    Arch Gen Psychiatry; 2000 Dec; 57(12):1165-73. PubMed ID: 11115331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropathology of Alzheimer's disease: a critical update.
    Jellinger KA; Bancher C
    J Neural Transm Suppl; 1998; 54():77-95. PubMed ID: 9850917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited effect of neuritic plaques on neuronal density in the hippocampal CA1 area of Alzheimer patients.
    Salehi A; Bakker JM; Mulder M; Swaab DF
    Alzheimer Dis Assoc Disord; 1998 Jun; 12(2):77-82. PubMed ID: 9651135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
    Yilmazer-Hanke DM; Hanke J
    Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies.
    Hansen LA; Masliah E; Quijada-Fawcett S; Rexin D
    Neurosci Lett; 1991 Aug; 129(2):269-72. PubMed ID: 1745407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression.
    Rapp MA; Schnaider-Beeri M; Purohit DP; Perl DP; Haroutunian V; Sano M
    Am J Geriatr Psychiatry; 2008 Feb; 16(2):168-74. PubMed ID: 18239198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroinflammation in Alzheimer's disease: protector or promoter?
    Zilka N; Ferencik M; Hulin I
    Bratisl Lek Listy; 2006; 107(9-10):374-83. PubMed ID: 17262990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.